Folgende Informationen sind nur auf Englisch verfügbar.

Novartis today announced a broad set of measures to support the global response to the COVID-19 pandemic. These measures include the creation of a global fund to support communities around the world impacted by the COVID-19 pandemic as well as the company’s decision to join two key cross-industry R&D initiatives.

The Novartis COVID-19 Response Fund will provide USD 20 million in grants to support public health initiatives designed to help communities manage challenges posed by the pandemic. The company has established an accelerated global review process that will allow for quick approval and disbursement of individual grants of up to USD 1 million. The fund is open to grant applications that will be processed through Novartis affiliates in the countries. The fund will seek to provide financial grants for initiatives focused on but not limited to the following areas:

• Strengthening local and national healthcare infrastructure including funding of additional medical personnel, sourcing of medicines and medical equipment
• Establishing digital platforms for COVID-19 related data collection, remote delivery of healthcare and effective dissemination of important public health information
• Creating new or enhancing new community health programs specific to the pandemic response